Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Innate immunity and intestinal microbiota in the development of Type 1 diabetes [Letter]

Wen, Li, Ley, Ruth E., Volchkov, Pavel Yu., Stranges, Peter B., Avanesyan, Lia, Stonebraker, Austin C., Hu, Changyun, Wong, Florence Susan, Szot, Gregory L., Bluestone, Jeffrey A., Gordon, Jeffrey I. and Chervonsky, Alexander V. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes [Letter]. Nature 455 (7216) , pp. 1109-1113. 10.1038/nature07336

Full text not available from this repository.

Abstract

Type 1 diabetes (T1D) is a debilitating autoimmune disease that results from T-cell-mediated destruction of insulin-producing β-cells. Its incidence has increased during the past several decades in developed countries1, 2, suggesting that changes in the environment (including the human microbial environment) may influence disease pathogenesis. The incidence of spontaneous T1D in non-obese diabetic (NOD) mice can be affected by the microbial environment in the animal housing facility3 or by exposure to microbial stimuli, such as injection with mycobacteria or various microbial products4, 5. Here we show that specific pathogen-free NOD mice lacking MyD88 protein (an adaptor for multiple innate immune receptors that recognize microbial stimuli) do not develop T1D. The effect is dependent on commensal microbes because germ-free MyD88-negative NOD mice develop robust diabetes, whereas colonization of these germ-free MyD88-negative NOD mice with a defined microbial consortium (representing bacterial phyla normally present in human gut) attenuates T1D. We also find that MyD88 deficiency changes the composition of the distal gut microbiota, and that exposure to the microbiota of specific pathogen-free MyD88-negative NOD donors attenuates T1D in germ-free NOD recipients. Together, these findings indicate that interaction of the intestinal microbes with the innate immune system is a critical epigenetic factor modifying T1D predisposition.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Systems Immunity Research Institute (SIURI)
Subjects: Q Science > QR Microbiology
R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
Publisher: Nature Publishing Group
ISSN: 0028-0836
Last Modified: 04 Jun 2017 04:20
URI: http://orca.cf.ac.uk/id/eprint/37144

Citation Data

Cited 1170 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item